REGULATORY & MEDICAL WRITING
REGULATORY & MEDICAL WRITING
Regulatory:
Each member of our core regulatory and medical writing team draws on extensive industry knowledge and therapeutic expertise to effectively meet our clients’ product development requirements and provide top-notch medical writing services. Each writer is a graduate-level life science scholar. They enhance their scientific and technical expertise through continuing medical education and study-specific training. Our writers also have access to internal therapeutic experts, researchers, and academics to gain sophisticated insight across many therapeutic specialties. Their experience and training enable them to expertly prepare reports in accordance with regional regulations and ICH Guidelines and to create clinical trial and regulatory documentation suitable for submission to regulatory authorities, including the FDA and EMA.
A well-designed and implemented regulatory strategy is critical to getting a product to market quickly and in a cost-effective manner. What sets Crescentyards apart from other CROs is that we only employ the most experienced personnel. The Crescentyards team has developed a deep understanding of the intricacies of the regulatory process that only comes with years of working within the FDA, and numerous pharmaceutical, device, and biotech companies, and various contract research organizations and other vendors.
Our Regulatory Services:

Regulatory Strategy

Investigational New Drug Application (IND)

Investigational Device Exemption (IDE)

New Drug Application (NDA)

Biologic License Application (BLA)

Premarket Approval (PMA)

Sponsor / FDA Liaison / Representation, Document Preparation, Review & Submission

Regulatory Response Preparation

Representation of clients with regulatory authorities

Safety narratives
Medical Writing
From the early stages, Stratum Clinical medical writers are involved in critical aspects of your projects, and we have clinical development expertise across all phases of drug development.
Our medical writers are here to assist you in the drug development lifecycle across Phase I to Phase IV. We have written clinical trial protocols, clinical study reports, briefing documents for regulatory meetings, and Investigator Brochures. Our documents follow ICH guidelines and are written to be fully compliant with all regulatory requirements.
Document types:

NDA, PMA

IND, BLA

Protocol development

Medical Publications

Clinical study reports (CSRs)

ClinicalTrials.gov publishing

Briefing document for regulatory interactions
